Pharm Tech Agenda 2015.03.11: Difference between revisions
Jump to navigation
Jump to search
| Line 28: | Line 28: | ||
=== Review of CPs === | === Review of CPs === | ||
* CP mtp-pre-1: link PRE --> MTP & type of referenced content | * CP mtp-pre-1: link PRE --> MTP & type of referenced content | ||
** [ftp://ftp.ihe.net/Pharmacy/TF_Maintenance-2015/CPs/Drafts/CP-PHARM-mtp-pre-1.doc Draft here] | |||
: | ** Goal: distinguish between reference to PRE and reference to MTP (same content) | ||
<p> </p> | |||
* CP mtp-pre-2: Reference to CDA | * CP mtp-pre-2: Reference to original CDA document (when in PML) | ||
** [ftp://ftp.ihe.net/Pharmacy/TF_Maintenance-2015/CPs/Drafts/CP-PHARM-mtp-pre-2.doc Draft here] | |||
: | ** Goal: when included in a PML, preserve the fact that several PREs or MTPs are coming from the same CDA document | ||
** Useful also for DIS and PADV? | |||
<p> </p> | |||
=== Review of CMPD Profile document === | === Review of CMPD Profile document === | ||
Revision as of 10:17, 10 March 2015
Meeting details
Wednesday, 11 March 2015, 14:00 CET
WebEx details:
Meeting number: 959 390 393
Call-in Numbers: Global Call-in numbers
Agenda
Review of MTP Profile document
- Glossary & definitions (pages 8, 10, 25)
- -
- Reported medications (page 16)
- -
- Next steps
- -
Review of CPs
- CP mtp-pre-1: link PRE --> MTP & type of referenced content
- Draft here
- Goal: distinguish between reference to PRE and reference to MTP (same content)
- CP mtp-pre-2: Reference to original CDA document (when in PML)
- Draft here
- Goal: when included in a PML, preserve the fact that several PREs or MTPs are coming from the same CDA document
- Useful also for DIS and PADV?
Review of CMPD Profile document
- - Document [1]
- -